Trump administration nixes plan to cover anti-obesity drugs through Medicare
Latest Stories from The Associated Press - A podcast by The Associated Press - Saturdays
The Trump’s administration has decided not to cover costly injectable drugs for obesity, under Medicare’s Part D prescription drug program. The AP's Jennifer King has more.
